Informaは企業と専門家を数百の方法でサポートしています。

私たちの国際的なライブイベント、世界をリードする研究出版物、革新的なデジタルサービスのポートフォリオは、専門家が成功するために必要な知識と人脈を提供しています。

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Branden Ryu, PhD
BIORCHESTRA Co., Ltd. における CEO
スピーカー

プロフィール

Branden Ryu (Jin-hyeob Ryu), Ph.D., is the Scientific Founder, Chairman, and Chief Executive Officer of BIORCHESTRA. He earned his Ph.D. in Pathology, Immunology and Microbiology from the University of Tokyo and previously conducted research at the Wellman Center within Harvard-MIT Health Sciences and Technology. He is an inventor of BIORCHESTRA’s core proprietary technologies, including the BDDS™ CNS delivery platform and therapeutic methods. Under his leadership, BIORCHESTRA has advanced RNA therapeutics for neurological diseases, established global R&D and partnering collaborations, and built a broad intellectual property portfolio.